Gufic Biosciences Investor Relations Material
Latest events
Q4 24/25
Gufic Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Gufic Biosciences Limited
Access all reports
Gufic Biosciences Limited is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical formulations, active pharmaceutical ingredients (APIs), and herbal products. The company specializes in injectables, lyophilized formulations, antifungals, antibiotics, and critical care medicines, catering to both domestic and international markets. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Key slides for Gufic Biosciences Limited
Q4 24/25
Gufic Biosciences Limited
Q3 24/25
Gufic Biosciences Limited
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
509079
Country
🇮🇳 India